Core Isogenics

Core Isogenics is a medical isotope company based in Columbia, Missouri, specializing in the production of high-purity radioisotopes for the radiopharmaceutical industry. The company's primary focus is the manufacturing of no-carrier-added (n.c.a.) Lutetium-177, a vital isotope used in targeted radionuclide therapies for cancers such as metastatic prostate cancer and neuroendocrine tumors. By employing advanced chemical separation and purification processes, Core Isogenics provides a reliable supply of isotopes that meet stringent pharmaceutical standards. Their operations are strategically positioned to support the growing global demand for theranostic applications in oncology.